Seban, R., Robert, C., Dercle, L., Yeh, R., Dunant, A., Reuze, S., . . . Deutsch, E. (2019). Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy. Oncoimmunology.
Chicago Style aipamenaSeban, Romain-David, et al. "Increased Bone Marrow SUVmax On 18F-FDG PET Is Associated With Higher Pelvic Treatment Failure in Patients With Cervical Cancer Treated By Chemoradiotherapy and Brachytherapy." Oncoimmunology 2019.
MLA aipamenaSeban, Romain-David, et al. "Increased Bone Marrow SUVmax On 18F-FDG PET Is Associated With Higher Pelvic Treatment Failure in Patients With Cervical Cancer Treated By Chemoradiotherapy and Brachytherapy." Oncoimmunology 2019.